177 results
Page 7 of 9
6-K
EX-99.1
hvfdroh
13 Apr 20
Enlivex Selected by the Israel Innovation Authority to Receive $1.5 Million Grant to Fund COVID-19 and Sepsis Clinical Trials
8:32am
6-K
EX-99.1
jxx ai3oa
18 Mar 20
Enlivex Announces Positive Final Safety and Efficacy Data From Clinical Trial of Off-The-Shelf Allocetra in Patients with Severe Sepsis
8:26am
6-K
EX-99.2
rwkk9nwm
5 Mar 20
Report of Foreign Private Issuer
8:16am
6-K
EX-1.1
c222l 1ctr7
5 Mar 20
Report of Foreign Private Issuer
8:16am
6-K
EX-99.1
oeies2bw7z9oapdx6
5 Mar 20
Report of Foreign Private Issuer
8:16am
424B5
ni88 ipfd0ubqlpy
3 Mar 20
Prospectus supplement for primary offering
5:13pm
6-K
EX-1.1
kj07he1leev0h9cnt
26 Feb 20
Enlivex Therapeutics Closes $8.0 Million Registered Direct Offering
4:15pm
6-K
EX-99.1
667m5y4xuc08dz7qjwyb
26 Feb 20
Enlivex Therapeutics Closes $8.0 Million Registered Direct Offering
4:15pm
424B5
96zx9yaazpb0
26 Feb 20
Prospectus supplement for primary offering
8:23am
6-K
EX-99.1
8cae3luvqekywkxbf
24 Feb 20
Report of Foreign Private Issuer
6:30am
20-F/A
1kk h7mpzo1t
23 Jan 20
Annual report (foreign) (amended)
4:31pm
424B5
fgx dnwl6
20 Nov 19
Prospectus supplement for primary offering
4:46pm
6-K
EX-99.2
xmr 018154sy
14 Nov 19
Condensed Consolidated Financial Statements
7:30am
6-K
EX-99.1
pqckqf8y ygc0x3r432
4 Nov 19
Enlivex Therapeutics Announces Positive Interim Safety and Efficacy Data From Ongoing Trial of Off-The-Shelf Allocetra in Patients with Severe Sepsis
7:30am
6-K
EX-99.1
c9erqol0ji vu
19 Aug 19
Report of Foreign Private Issuer
7:31am
6-K
EX-99.2
w3ox02lamzaqxrro
26 Jul 19
Condensed Consolidated Financial Statements
4:32pm
6-K
EX-99.1
041 muj2nucuis7uayl
16 Jul 19
Immunotherapy Company Enlivex Announces Dual Listing on the Tel-Aviv Stock Exchange
7:32am
424B3
ykheb
10 Jul 19
Prospectus supplement
8:18am
F-3
bhi0t9lvww7spyv1du
28 Jun 19
Shelf registration (foreign)
9:48am